Why the evidence for skin cancer screening is insufficient: Lessons from prostate cancer screening

Archives of Dermatology

Volumn 146, Issue 3, 2010, Pages 322-324

  Bigby, Michael ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER SCREENING; DIAGNOSTIC ACCURACY; HUMAN; MORBIDITY; NOTE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSTATE CANCER; SELF EXAMINATION; SKIN CANCER;

EARLY DETECTION OF CANCER; HUMANS; INCIDENCE; MALE; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SKIN NEOPLASMS; UNITED STATES;

EID: 77949362912     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.18     Document Type: Note

References (13)

1. Schröder FH, Hugosson J, Roobol MJ, et al; ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360(13):1320-1328.
2. Andriole GL, Crawford ED, Grubb RL III, et al; PLCO Project Team. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360(13):1310-1319.
3. Sandblom G, Varenhorst E, Löfman O, Rosell J, Carlsson P. Clinical consequences of screening for prostate cancer: 15 years follow-up of a randomised controlled trial in Sweden. Eur Urol. 2004;46(6):717-725.
4. Labrie F, Candas B, Dupont A, et al. Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial. Prostate. 1999;38(2):83-91.
5. Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force. Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(3):192-199.
6. U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(3):185-191.
7. Brawley OW, Ankerst DP, Thompson IM. Screening for prostate cancer. CA Cancer J Clin. 2009;59(4):264-273.
8. U.S. Preventive Services Task Force. Screening for skin cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;150(3):188-193.
9. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics 2009. CA Cancer J Clin. 2009;59(4):225-249.
10. Aitken JF, Elwood JM, Lowe JB, Firman DW, Balanda KP, Ring IT. A randomised trial of population screening for melanoma. J Med Screen. 2002;9(1):33-37.
11. U.S. Preventive Services Task Force. Screening for breast cancer: recommendations and rationale. Ann Intern Med. 2002;137(5, pt 1):344-346.
12. Screening for skin cancer: a clinical practice guideline. Program in Evidence-based Care (PEBC), Cancer Care Ontario (CCO) Web site. http://www.cancercare.on.ca/pdf/pebc15-1s.pdf. Accessed January 7, 2010.
13. Wise E, Singh D, Moore M, et al. Rates of skin cancer screening and prevention counseling by US medical residents. Arch Dermatol. 2009;145(10):1131-1136.